Nasdaq:US$18.12 (-0.52) | HKEX:HK$28.55 (-0.20) | AIM:£2.93 (-0.03)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture